| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.83▲ | 0.83▲ | 0.83▲ | 0.89▼ | 0.77▲ |
| MA10 | 0.83▲ | 0.83▲ | 0.84▼ | 0.83▲ | 0.77▲ |
| MA20 | 0.83▲ | 0.84▼ | 0.87▼ | 0.77▲ | 0.81▲ |
| MA50 | 0.83▲ | 0.89▼ | 0.86▼ | 0.76▲ | 2.93▼ |
| MA100 | 0.85▼ | 0.85▼ | 0.79▲ | 0.82▲ | N/A |
| MA200 | 0.89▼ | 0.78▲ | 0.76▲ | 2.81▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.002▲ | -0.006▼ | 0.014▲ | 0.108▲ |
| RSI | 53.650▲ | 42.417▼ | 43.193▼ | 54.439▲ | 35.191▼ |
| STOCH | 72.795 | 58.536 | 22.321 | 66.344 | 48.080 |
| WILL %R | -11.340▲ | -56.636 | -73.606 | -55.637 | -51.450 |
| CCI | 74.671 | -18.075 | -57.901 | 25.353 | 208.533▲ |
|
Tuesday, February 03, 2026 05:19 AM
Meeting with the FDA to review the results from the Phase 3 EFZO-FIT™ study and determine the path forward for efzofitimod in pulmonary sarcoidosis is scheduled for mid-April 2026. SAN DIEGO, Feb. 03, ...
|
|
Friday, January 02, 2026 04:51 PM
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company ...
|
|
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
Monday, December 08, 2025 05:36 AM
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/02/26 | 0.8378 | 0.8378 | 0.8234 | 0.8342 | 521,057 |
| 05/02/26 | 0.86 | 0.90 | 0.8102 | 0.8107 | 2,008,239 |
| 04/02/26 | 0.961 | 1.03 | 0.87 | 0.8805 | 2,024,323 |
| 03/02/26 | 0.9771 | 1.04 | 0.87 | 0.9602 | 3,547,721 |
| 02/02/26 | 0.88 | 1.02 | 0.8701 | 0.9702 | 7,245,259 |
| 30/01/26 | 0.841 | 0.8867 | 0.8204 | 0.8828 | 3,088,700 |
| 29/01/26 | 0.75 | 0.8949 | 0.74 | 0.8506 | 15,677,396 |
| 28/01/26 | 0.701 | 0.7101 | 0.6701 | 0.6742 | 880,442 |
| 27/01/26 | 0.7018 | 0.72 | 0.69 | 0.707 | 859,748 |
| 26/01/26 | 0.71 | 0.7337 | 0.7003 | 0.7007 | 1,146,979 |
|
|
||||
|
|
||||
|
|